Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00097435 · ClinicalTrials.gov registry record · Phase 2

A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C

A Phase 2 study of Hepatitis C, sponsored by Human Genome Sciences.

Completed
Registry status
Phase 2
Development phase
115
Enrollment target
8
Study locations

NCT00097435 is a Phase 2 study of Hepatitis C that has completed, run by Human Genome Sciences. The registered enrollment target is 115 participants, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (94% lower). The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00097435, a Phase 2 study of Hepatitis C, has completed, sponsored by Human Genome Sciences.

COMPLETED
Registry status
Phase 2
Development phase
115 participants
Enrollment target
8
Study locations

Study Summary

This is a Phase 2, multi-center, randomized, open-label study to evaluate the safety, tolerability, and efficacy of Albuferon in subjects with hepatitis C (HEP C) who failed to respond to previous interferon alfa therapy.

Conditions Studied

Hepatitis C

Interventions

  • DRUG Albuferon
  • DRUG Ribavirin

Study Locations (8)

Florida

  • University of Florida CRC - Gainesville
  • University of Florida at Jacksonville - Jacksonville
  • Mayo Clinic Jacksonville - Jacksonville

Arizona

  • Mayo Clinic - Phoenix

Maryland

  • Johns Hopkins University - Baltimore

Minnesota

  • Mayo Clinic Rochester - Rochester

North Carolina

  • Duke University - Durham

Virginia

  • Metropolitan Research - Fairfax

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2004-10
Est. Completion 2007-08
Phase Phase 2

Sponsor

Human Genome Sciences

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00097435

The ClinicalTrials.gov registry entry for NCT00097435 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (94% lower). The listed sponsor is Human Genome Sciences, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 2 interventions - of which Albuferon is the first listed.

NCT00097435 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Florida, Arizona, Maryland.

Frequently Asked Questions

What is clinical trial NCT00097435 about?

NCT00097435 is a clinical study titled "A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C". This is a Phase 2, multi-center, randomized, open-label study to evaluate the safety, tolerability, and efficacy of Albuferon in subjects with hepatitis C (HEP C) who failed to respond to previous interferon alfa therapy.

What is the current status of trial NCT00097435?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 115 participants. The study started on 2004-10. Estimated completion is 2007-08.

What conditions does trial NCT00097435 study?

This clinical trial studies the following conditions: Hepatitis C.

What interventions are being tested in trial NCT00097435?

The interventions under investigation include: Albuferon (DRUG), Ribavirin (DRUG).

Who is sponsoring clinical trial NCT00097435?

This trial is sponsored by Human Genome Sciences, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00097435 being conducted?

This trial has 8 study locations across Arizona, Florida, Maryland, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis C

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.